TransMedics Group, Inc. (NasdaqGM: TMDX)
Health Care · Health Care Equipment & Supplies · US
$94.77
+4.31% today · -20.2% 1Y
TransMedics Group, Inc. (NasdaqGM: TMDX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $3.29B and employs 898 people.
Over the last twelve months the share price has lost 20.2%, trading between 60.11 and 156.00.
Tweenvest scores TransMedics Group, Inc. across four factors: quality 60/100, value 49/100, growth 100/100. Its strongest factor is growth.
TMDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.29B
- Revenue (TTM)
- $668.47M
- P/E
- 23.61
- EPS
- 4.01
- Dividend yield
- —
- Beta (5Y)
- 1.88
- 52-week high
- $156.00
- 52-week low
- $60.11
- Avg volume (3M)
- —
- Shares outstanding
- 34.68M
- Employees
- 898
- Next earnings
- —
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Founded
- 1998
- Listed since
- May 2, 2019
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.